gen-004
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT01995617)
Timeline
Indications
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gen-004
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02116998 | Phase 2 | Sep 1, 2014 | Genocea Biosciences, Inc., Royal Liverpool & Broadgreen University Hospitals NHS Truts |
| NCT01995617 | Phase 1 | Nov 1, 2013 | Genocea Biosciences, Inc., Prism Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genocea Biosciences, Inc. | For profit | 2 | 2 | 2 | 2013 |
| Prism Research | For profit | 1 | 0 | 1 | 2013 |
| Royal Liverpool & Broadgreen University Hospitals NHS Truts | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1